| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 04/04/2013 | CA2849471A1 Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus |
| 04/03/2013 | EP2574631A1 Filler for affinity chromatography and method for isolating immunoglobulin |
| 04/03/2013 | CN103025762A New medium, devices and methods |
| 04/03/2013 | CN103013976A Method for preparing organic-inorganic composite hydrogel membrane and grafting material containing immobilized biological macromolecules |
| 04/03/2013 | CN103012594A Nano-carrier of carrying porcine circovirus antigen epitope protein and application thereof |
| 04/03/2013 | CN103012562A Dual-targeting D-configuration polypeptides and drug delivery system thereof |
| 04/02/2013 | US8410252 ULBP2 polypeptides |
| 04/02/2013 | US8410061 Variants of hedgehog protein that contain N-terminal modifications are described that can block hedgehog function; thus allowing these variants to serve as functional antagonists. These peptides have a primary amino acid sequence |
| 04/02/2013 | US8409836 Treatment of cellulosic material and enzymes useful therein |
| 04/02/2013 | US8409817 Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
| 04/02/2013 | US8409814 Sensor proteins and assay methods |
| 04/02/2013 | US8409605 Biocompatible material composition adaptable to diverse therapeutic indications |
| 03/28/2013 | US20130079499 Fc binding protein and method for manufacturing same |
| 03/28/2013 | US20130079390 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
| 03/28/2013 | US20130079283 Erythropoitein Receptor Peptide Formulations and Uses |
| 03/28/2013 | US20130078739 Cortisol immunoassay using fluorescent particles |
| 03/28/2013 | US20130078646 Antibodies, compositions, and assays for detection of cardiac disease |
| 03/27/2013 | EP2573114A1 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 03/27/2013 | EP2573103A1 Peptide domains that bind small molecules of industrial significance |
| 03/27/2013 | EP2573102A1 Peptide domains that bind small molecules of industrial significance |
| 03/27/2013 | EP2571896A2 Pegylated c-peptide |
| 03/27/2013 | EP2571532A2 Il-1 binding proteins |
| 03/27/2013 | CN1913920B Influenza immunogen and vaccine |
| 03/27/2013 | CN101381409B N-terminally chemically modified protein compositions and methods |
| 03/27/2013 | CN101374955B Targeting vector-phospholipid conjugates |
| 03/21/2013 | WO2013039190A1 Peptide-containing polymer, and method for peptide immobilization on fiber |
| 03/21/2013 | WO2013038158A1 Intracellular cell selection |
| 03/21/2013 | US20130071428 Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| 03/21/2013 | CA2848403A1 Hyr1-derived compositions and methods of treatment using same |
| 03/20/2013 | EP2569338A1 Binding systems |
| 03/20/2013 | CN101870732B Method for synthesizing mono pegylation-thymopentin by solid phase and liquid phase combination |
| 03/20/2013 | CA2783359A1 Opioid peptide esters and methods of use |
| 03/19/2013 | US8399618 Immunoglobulin insertions, deletions, and substitutions |
| 03/19/2013 | US8399383 Used to assay simultaneously the presence, amount, and/or function of proteins present in a protein sample/chip, or to assay the presence, relative specificity, and binding affinity of each probe in a mixture of probes for each of the proteins |
| 03/14/2013 | WO2013033838A1 Liposomal formulations of cationic peptides and uses thereof |
| 03/14/2013 | WO2012173422A9 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof |
| 03/14/2013 | WO2012172346A3 Treating respiratory conditions |
| 03/14/2013 | WO2012172344A3 Treating conditions associated with sepsis |
| 03/14/2013 | WO2012120535A3 A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same |
| 03/14/2013 | US20130066055 New binder-drug conjugates (adcs) and use thereof |
| 03/14/2013 | US20130065238 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
| 03/14/2013 | US20130064842 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) |
| 03/13/2013 | EP2566881A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications |
| 03/13/2013 | CN101511391B N-terminal polysialylation |
| 03/13/2013 | CN101208357B Affinity ligands |
| 03/12/2013 | US8394758 Tumor-targeting peptides and uses thereof |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/07/2013 | WO2013033359A1 Carbon nanotube biosensors and related methods |
| 03/07/2013 | WO2013029472A1 Composition, kit and use thereof for quickly extracting unrelated circulating nucleated cell from peripheral blood of diseased animal model |
| 03/07/2013 | WO2013029182A1 Stable peptide-based furin inhibitors |
| 03/07/2013 | WO2013029180A1 Stable peptide-based pace4 inhibitors |
| 03/07/2013 | WO2013009690A3 Leukemia stem cell targeting ligands and methods of use |
| 03/07/2013 | WO2012172347A9 Diagnosing and treating inflammatory bowel disease and irritable bowel syndrome |
| 03/07/2013 | WO2012172345A3 Treating conditions associated with allergy |
| 03/07/2013 | WO2012172343A3 Treating primary sclerosing cholangitis |
| 03/07/2013 | WO2012172342A3 Treating multiple sclerosis |
| 03/07/2013 | WO2012172340A3 Treating mental disorders |
| 03/07/2013 | WO2012172339A3 Treating inflammatory arthritis |
| 03/07/2013 | WO2012172337A3 Treating cardiovascular disease |
| 03/07/2013 | WO2012172336A3 Treating inflammatory skin diseases |
| 03/07/2013 | US20130058994 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 03/07/2013 | CA2846287A1 Stable peptide-based pace4 inhibitors |
| 03/06/2013 | CN1727471B Application of alcohol soluble film in protein ground substance from source of plants |
| 03/06/2013 | CN102952067A Pyridoxal derivative for pegylation modification of N terminal of protein and preparation method and application thereof |
| 03/05/2013 | US8389695 Selenium containing modifying agents and conjugates |
| 03/05/2013 | US8389684 Tumor biomarker |
| 03/05/2013 | US8389481 Glutamate-enhanced cell-penetrating peptides and methods of using same |
| 03/05/2013 | US8388973 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/28/2013 | WO2013027796A1 IgG-BINDING PEPTIDE AND METHOD FOR DETECTING AND PURIFYING IgG USING SAME |
| 02/28/2013 | WO2007025388A9 Anti-apoptotic protein antibodies |
| 02/28/2013 | US20130053301 Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| 02/28/2013 | US20130052653 Devices for detection of analytes |
| 02/28/2013 | US20130052204 (poly)-glycerolphosphate-based anti-gram positive bacterial vaccine |
| 02/28/2013 | US20130052155 Compositions and Methods for Treating a Disorder or Defect in Soft Tissue |
| 02/28/2013 | CA2846092A1 Peg-interferon lambda 1 conjugates |
| 02/27/2013 | CN102947340A Binding systems |
| 02/27/2013 | CN102947324A Peptide domains that bind small molecules of industrial significance |
| 02/26/2013 | US8383919 Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof |
| 02/26/2013 | US8383782 Composite materials comprising supported porous gels |
| 02/26/2013 | US8383774 Collectin fusion proteins comprising TNF or trail |
| 02/26/2013 | US8383772 Ang-(1-7) receptor agonist |
| 02/26/2013 | US8383125 Antimicrobial protein |
| 02/26/2013 | US8383121 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof |
| 02/26/2013 | US8383107 Single domain brain-targeting antibody fragments derived from llama antibodies |
| 02/26/2013 | CA2493822C Methods and compositions for targeting secretory lysosomes |
| 02/21/2013 | WO2013025052A2 Bioactive carbon nanotube composite functionalized with β-sheet polypeptide block copolymer, and preparation method thereof |
| 02/21/2013 | US20130045917 Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof |
| 02/21/2013 | US20130045533 Modular transport platform for targeted delivery of therapeutic agents |
| 02/21/2013 | US20130045490 Antibody against mucin 1 (muc1) protein and use of same |
| 02/21/2013 | US20130045480 Novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes - useful or detection or quantification of desirable target molecules |
| 02/21/2013 | US20130045475 2-Nitrobenzyl-Modified Ribonucleotides |
| 02/20/2013 | EP2559707A2 PP1 ligands |
| 02/20/2013 | EP2558502A1 Tumor cell-derived microvesicles |
| 02/20/2013 | CN102936321A Living polymerization preparation method for polyacrylic acid ball brush and application of polyacrylic acid ball brush |
| 02/19/2013 | USRE44022 Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activators |
| 02/19/2013 | US8378074 High affinity HIV T cell receptors |
| 02/19/2013 | US8378071 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 02/19/2013 | US8378064 Hydrophilic polymers as medical lubricants and gels |
| 02/19/2013 | US8377864 Fibrin gel for controlled release of PDGF and uses thereof |
| 02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |